Value Hunters: Look To Lineage Cell Therapeutics Inc (LCTX)
Currently, there are 188.84M common shares owned by the public and among those 188.00M shares have been available to trade. The company’s stock has a 5-day price change of -6.77% and -11.61% over the past three months. LCTX shares are trading -18.91% year to date (YTD), with the 12-month market performance down to -34.53% lower. […]
